Abstract
There are currently no studies that have examined the clinicopathological factors in detail, including the histological images of the invasive front, and the risk of lymph node metastasis (LNM) in superficial oesophageal squamous cell carcinoma (SESCC). This study aimed to develop an algorithm that contributes to a better assessment of the risk of LNM and recurrence in SESCC. Clinicopathological factors, such as submucosal (SM) invasion distance, were examined in 88 surgically resected cases of SESCC. An SM invasion distance of 600 μm was the statistically best customer value for LNM (p = 0.0043). To obtain a histological image of the invasive front, we evaluated modified tumour budding (MBD) by modifying the number of tumour foci constituent cells and foci in tumour budding. We also evaluated the smallest number of tumour foci. Using these factors, we developed an algorithm to predict the risk of LNM. The best algorithm was created using an SM invasion distance of 600 μm and an index of 5 or more foci consisting of five or fewer tumour cells in the MBD (MBD5 high-grade ≥ 5), which was also significantly associated with recurrence-free survival (p = 0.0305). Further study of the algorithm presented in this study is expected to improve the quality of life of patients by selecting appropriate additional treatments after endoscopic resection and appropriate initial treatment for SESCC.
Similar content being viewed by others
Data availability
Data sharing is not applicable to this article as no new data were created or analysed in this study.
References
Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182–188
Kitagawa Y, Ishihara R, Ishikawa H, et al (2023) Esophageal cancer practice guidelines 2022 edited by the Japan esophageal Society: part 1. Esophagus. https://doi.org/10.1007/s10388-023-00993-2
Kitagawa Y, Ishihara R, Ishikawa H et al (2023) Esophageal cancer practice guidelines 2022 edited by the Japan esophageal Society: part 2. Esophagus. https://doi.org/10.1007/s10388-023-00994-1
Akutsu Y, Uesato M, Shuto K et al (2013) The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg 257:1032–1038
Dubecz A, Kern M, Solymosi N et al (2015) Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg 99:1879–1886
Hölscher AH, Stahl M, Messmann H et al (2016) New S3 guideline for esophageal cancer Important surgical aspects. Der Chirurg 87:865–872
Pimentel-Nunens P, Libânio D, Bastiaansen BAJ et al (2022) Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022. Endoscopy. https://doi.org/10.1055/a-1811-7025
Odagiri H, Yasunaga H (2017) Complications following endoscopic submucosal dissection for gastric, esophageal, and colorectal cancer: a review of studies based on nationwide large-scale databases. Ann Transl Med 5:189
Keiko M (2020) Endoscopic resection and selective chemoradiotherapy for stage I esophageal cancer. Gastrointest Endosc 62:2931–2939
Matsubara H, Ando N, Nemoto K et al (2017) Japanese classification of esophageal cancer, 11th Edition: part I. Esophagus 14:1–36
Kai-Yuan J, Heng H, Wei-Yang C et al (2021) Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis. World J Gastroenterol 27:737–750
Yachida T, Oda I, Abe S et al (2020) Risk of lymph node metastasis in patients with the superficial spreading type of esophageal squamous cell carcinoma. Digestion 101:239–244
Egashira H, Yanagisawa A, Kato Y (2006) Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae: the utility of droplet infiltration. Esophagus 3:47–52
Fuchinoue K, Nemoto T, Shimada H et al (2020) Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma. Esophagus 17:168–174
Koike M, Kodera Y, Itoh Y et al (2008) Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol 15:1977–1982
Roh MS, Lee JI, Choi PJ (2004) Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 17:333–337
Hashiguchi Y, Muro K, Saito Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42
Miyata H, Yoshioka A, Yamasaki M et al (2009) Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 115:3324–3334
Lugli A, Kirsch R, Ajioka Y et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30:1299–1311
Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132
Berg KB, Schaeffer DF (2018) Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon. Mod Pathol 31:862–872
Landau M, Hastings S, Foxwell T et al (2014) Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 27:1578–1589
Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, Chichester
Kotake K, Inomata M, Ajioka Y et al (2019) Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition. J Anus Rectum Colon 3:175–195
Takubo K, Aida J, Sawabe M et al (2007) Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint. Histopathology 51:733–742
Niwa Y, Yamada S, Koike M et al (2014) Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. J Surg Oncol 110:764–769
Bartis D, Mise N, Mahida RY, Eickelberg O, Thickett DR (2014) Epithelial-mesenchymal transition in lung development and disease: Does it exist and is it important? Thorax 69:760–765
Li M, Bu X, Cai B et al (2019) Biological role of metabolic reprogramming of cancer cells during epithelial-mesenchymal transition (Review). Oncol Rep 41:727–741
Zhang J, luo A, Huang F, Gong T, Liu Z, (2020) SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Cancer Lett 469:390–398
Masugi Y, Yamazaki K, Hibi T, Aiura K, Kitagawa Y, Sakamoto M (2010) Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. Hum Pathol 41:1061–1068
Karamitopoulou E, Zlobec I, Born D et al (2013) Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer 49:1032–1039
Karamitopoulou E, Haemmig S, Baumgartner U, Schlup C, Wartenberg M, Vassella E (2017) MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer. Mod Pathol 30:1116–1125
Petrova E, Zielinski V, Bolm L et al (2020) Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma. Virchows Arch 476:561–568
Namikawa K, Yoshio T, Yoshimizu S et al (2021) Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma. Sci Rep 11:6554
Acknowledgements
We would like to thank Editage (www.editage.com) for English language editing.
Compliance with ethical standards
All the performed procedures involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments.
Research involving animals
No animals were involved in the present study.
Informed consent
Informed consent was obtained from all the patients to anonymously report relevant clinical information and histologic findings related to their tumours.
Funding
This study was funded by Japan Society for the Promotion of Science (award number: 21K06922, recipient: Kenichi Ohashi).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1.
Supplementary Figure. A study focusing on the characteristics of the smallest tumour foci. a the number of cells constituting the smallest tumour foci, b the smallest tumour foci size, c the distance from the main lesion of the smallest tumour foci.
Additional file 2.
Supplementary Table 1. Histopathological features of invasive front as stratified by lymph node metastasis status.
Additional file 3.
Supplementary Table 2. Cox proportional hazard regression model of clinicopathological features related to recurrence-free survival.
Additional file 4.
Supplementary Table 3. Risk assessment algorithm for lymph node metastasis in superficial oesophageal squamous cell carcinoma cases.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kato, Y., Ito, T., Yamamoto, K. et al. Invasive features of superficial oesophageal squamous cell carcinoma—analysis of risk factors for lymph node metastasis. Virchows Arch 483, 645–653 (2023). https://doi.org/10.1007/s00428-023-03582-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-023-03582-x